Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study
Harald Jörn Schneider
Medizinische Klinik, Ludwig-Maximilian-University, Innenstadt, Munich, Germany
Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
Search for more papers by this authorCaroline Sievers
Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
Search for more papers by this authorJens Klotsche
Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany
Search for more papers by this authorSteffen Böhler
Institute of Clinical Pharmacology, Technical University of Dresden, Dresden , Germany
Search for more papers by this authorDavid Pittrow
Institute of Clinical Pharmacology, Technical University of Dresden, Dresden , Germany
Search for more papers by this authorHendrik Lehnert
Warwick Medical School, University Hospital of Coventry, Coventry, UK
First Medical Department, University of Luebeck, Germany
Search for more papers by this authorHans-Ulrich Wittchen
Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany
Search for more papers by this authorGünter Karl Stalla
Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
Search for more papers by this authorHarald Jörn Schneider
Medizinische Klinik, Ludwig-Maximilian-University, Innenstadt, Munich, Germany
Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
Search for more papers by this authorCaroline Sievers
Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
Search for more papers by this authorJens Klotsche
Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany
Search for more papers by this authorSteffen Böhler
Institute of Clinical Pharmacology, Technical University of Dresden, Dresden , Germany
Search for more papers by this authorDavid Pittrow
Institute of Clinical Pharmacology, Technical University of Dresden, Dresden , Germany
Search for more papers by this authorHendrik Lehnert
Warwick Medical School, University Hospital of Coventry, Coventry, UK
First Medical Department, University of Luebeck, Germany
Search for more papers by this authorHans-Ulrich Wittchen
Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany
Search for more papers by this authorGünter Karl Stalla
Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
Search for more papers by this authorSummary
Objective Low testosterone levels in men occur with increasing age and are associated with increased morbidity, particularly metabolic syndrome, and mortality. As the prevalence of hypogonadal testosterone levels has not been assessed in the primary care setting in Europe, we aimed to investigate the prevalence of low testosterone levels in this setting, and the patient characteristics and comorbidities associated with this finding.
Design A cross-sectional, epidemiological study (the Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study).
Patients A total of 2719 male primary care patients (age 58·7 ± 13·4 years) were included.
Measurements Testosterone was measured in all patients. Information on diseases, risk conditions and treatments was documented by the primary care physicians. A large set of laboratory parameters was measured in a central laboratory. We calculated univariate and multivariate logistic regression models to assess the associations of low testosterone levels with different health and life style factors.
Results A total of 19·3% of all men had hypogonadism as defined by testosterone levels < 3·0 ng/ml. Stepwise logistic regression analysis revealed that obesity, metabolic syndrome, cancer, intake of six or more drugs, acute inflammation and nonsmoking were associated with hypogonadal testosterone levels. Higher age, liver diseases, and cancer were associated with very low testosterone levels (< 1·0 ng/ml).
Conclusions Hypogonadal testosterone levels are common in primary care, particularly in patients with the above conditions.
References
- 1 Seftel, A. (2006) Male hypogonadism. Part II: Etiology, pathophysiology, and diagnosis. International Journal of Impotence Research, 18, 223–228.
- 2 Travison, T.G., Araujo, A.B., Kupelian, V. et al. (2007) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology and Metabolism, 92, 549–555.
- 3 Laaksonen, D.E., Niskanen, L., Punnonen, K. et al. (2003) Sex hormones, inflammation and the metabolic syndrome: a population-based study. European Journal of Endocrinology, 149, 601–608.
- 4 Laaksonen, D.E., Niskanen, L., Punnonen, K. et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care, 27, 1036–1041.
- 5 Laaksonen, D.E., Niskanen, L., Punnonen, K. et al. (2005) The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. Journal of Clinical Endocrinology and Metabolism, 90, 712–719.
- 6 Rodriguez, A., Muller, D.C., Metter, E.J. et al. (2007) Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. Journal of Clinical Endocrinology and Metabolism, 92, 3568–3572.
- 7 Ferrucci, L., Maggio, M., Bandinelli, S. et al. (2006) Low testosterone levels and the risk of anemia in older men and women. Archives of Internal Medicine, 166, 1380–1388.
- 8 Laughlin, G.A., Barrett-Connor, E. & Bergstrom, J. (2008) Low Serum Testosterone and Mortality in Older Men. Journal of Clinical Endocrinology and Metabolism, 93, 68–75.
- 9 Khaw, K.T., Dowsett, M., Folkerd, E. et al. (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation, 6, 2694–2701.
- 10 Kaufman, J.M. & Vermeulen, A. (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Review, 26, 833–876.
- 11 Nieschlag, E., Behre, H.M., Bouchard, P. et al. (2004) Testosterone replacement therapy: current trends and future directions. Human Reproduction Update, 10, 409–419.
- 12 Vermeulen, A. & Kaufman, J.M. (2002) Diagnosis of hypogonadism in the aging male. The Aging Male, 5, 170–176.
- 13 Bhasin, S., Woodhouse, L., Casaburi, R. et al. (2001) Testosterone dose–response relationships in healthy young men. American Journal of Physiology. Endocrinology and Metabolism, 281, E1172–E1181.
- 14 Snyder, P.J., Peachey, H., Hannoush, P. et al. (1999) Effect of testosterone treatment on bone mineral density in men over 65 years of age. Journal of Clinical Endocrinology and Metabolism, 84, 1966–1972.
- 15 Swerdloff, R.S. & Wang, C. (2003) Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel. The Aging Male, 6, 207–211.
- 16 Kelleher, S., Conway, A.J. & Handelsman, D.J. (2004) Blood testosterone threshold for androgen deficiency symptoms. Journal of Clinical Endocrinology and Metabolism, 89, 3813–3817.
- 17 Harman, S.M., Metter, E.J., Tobin, J.D. et al. (2001) Baltimore longitudinal study of aging. longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. Journal of Clinical Endocrinology and Metabolism, 86, 724–731.
- 18 Feldman, H.A., Longcope, C., Derby, C.A. et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. Journal of Clinical Endocrinology and Metabolism, 87, 589–598.
- 19 Travison, T.G., Araujo, A.B., O'Donnell, A.B. et al. (2007b) A population-level decline in serum testosterone levels in American men. Journal of Clinical Endocrinology and Metabolism, 92, 196–202.
- 20 Andersson, A.-M., Jensen, T.K., Juul, A. et al. (2007) Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. Journal of Clinical Endocrinology and Metabolism, 92, 4696–4705.
- 21 Amin, S., Zhang, Y., Sawin, C.T. et al. (2000) Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Annals of Internal Medicine, 133, 951–963.
- 22 Araujo, A.B., Esche, G.R., Kupelian, V. et al. (2007) Prevalence of symptomatic androgen deficiency in men. Journal of Clinical Endocrinology and Metabolism, 92, 4241–4247.
- 23 Mulligan, T., Frick, M.F., Zuraw, Q.C. et al. (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. International Journal of Clinical Practice, 60, 762–769.
- 24 Grundy, S.M., Cleeman, J.I., Daniels, S.R. et al. (2005) American heart association; national heart, lung, and blood Institute. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation, 112, 2735–2752.
- 25 Wittchen, H.U., Glaesmer, H., März, W. et al. (2005) Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program. Current Medical Research Opinions, 21, 619–630.
- 26 Von Elm, E., Altman, D.G., Egger, M. et al. (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of Internal Medicine, 147, 573–577.
- 27 Muller, M., Den Tonkelaar, I., Thijssen, J.H. et al. (2003) Endogenous sex hormones in men aged 40–80 years. European Journal of Endocrinology, 149, 583–589.
- 28 Kupelian, V., Page, S.T., Araujo, A.B. et al. (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology and Metabolism, 91, 843–850.
- 29 Schneider, H.J., Klotsche, J., Stalla, G.K. et al. (2006) Obesity and risk of myocardial infarction: the INTERHEART study. Lancet, 367, 1052.
- 30 Schneider, H.J., Glaesmer, H., Klotsche, J. et al.. (2007) Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 92, 589–594.
- 31 Svartberg, J. (2007) Epidemiology: testosterone and the metabolic syndrome. International Journal of Impotence Research, 19, 124–128.
- 32 Karagiannis, A. & Harsoulis, F. (2005) Gonadal dysfunction in systemic diseases. European Journal of Endocrinology, 152, 501–513.
- 33 Field, A.E., Colditz, G.A., Willett, W.C. et al. (1994) The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. Journal of Clinical Endocrinology and Metabolism, 79, 1310–1316.
- 34 English, K.M., Pugh, P.J., Parry, H. et al. (2001) Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clinical Science, 100, 661–665.
- 35 Svartberg, J., Midtby, M., Bønaa, K.H. et al. (2003) The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study. European Journal of Endocrinology, 149, 145–152.
- 36 Wang, C., Catlin, D.H., Demers, L.M. et al. (2004) Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 89, 534–543.
- 37 Pittrow, D., Pieper, L., Klotsche, J. et al. (2007) DETECT: Ergebnisse einer klinisch-epidemiologischen Querschnitts-und Verlaufsstudie Mit 55.000 Patienten in 3.000 Hausarztpraxen. Urban & Fischer, München.
- 38 Bhasin, S., Cunningham, G.R., Hayes, F.J. et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 1995–2010.
Citing Literature
